Copyright
        ©2013 Baishideng Publishing Group Co.
    
    
        World J Transplant. Dec 24, 2013; 3(4): 78-90
Published online Dec 24, 2013. doi: 10.5500/wjt.v3.i4.78
Published online Dec 24, 2013. doi: 10.5500/wjt.v3.i4.78
            Table 1 Summary of some of the observational studies describing the VO2peak levels in heart transplant recipients
        
    | Study | n | Mean age (yr) | Mean time after HTx | VO2peak: mL/kg per minute or L/min | VO2peak (% of age-predicted value) | Percent of age-predicted HRmax or actual HRmax (bpm) | 
| Renlund et al[123] | 110 | 51 ± 10 | 26 mo | 17.7 ± 0.3 mL | 64% ± 1% | 85% | 
| Mandak et al[51] | 60 | 52 ± 10 | 1 yr | 16.2 ± 3.8 mL | NA | 137 ± 24 | 
| Osada et al[124] | 56 | 50 ± 12 | 3 yr | 20.0 ± 5.0 mL | 70% ± 17% | 88% ± 11% | 
| Notarius et al[12] | 12 | 51 ± 4 | 8 mo | 17.3 ± 1.7 mL | 57% | 147 ± 7 | 
| Douard et al[30] | 85 | 52 ± 12 | 0-100 mo | 21.1 ± 6 mL | NA | 85% ± 13% | 
| Squires et al[24] | 95 | 48 ± 14 | 1 yr | 19.9 ± 4.8 mL | 61% ± 15% | 138 ± 22 | 
| Gullestad et al[48] | 174 | 51 ± 1 | 3.5 yr | 19.4 ± 0.4 mL | 70% ± 1% | 146 ± 2 | 
| Myers et al[125] | 47 | 47 ± 12 | 4.8 yr | 9.4 ± 2.6 mL | 59% ± 14% | 129 ± 18 | 
| Schmid et al[126] | 17 | 58 ± 13 | 65 ± 27 | 20.9 ± 5.2 mL | NA | 136 ± 12 | 
| Richard et al[127] | 7 | 40 ± 13 | 2 yr | NA | 101% ± 12% | 93% ± 9% | 
| Carter et al[2] | 47 | 48 | 5 yr | 16.1 ± 0.5 mL | 51% ± 1.5% | 74% ± 1% | 
| Ulubay et al[118] | 7 | 43 ± 14 | 19 mo | 1.45 ± 0.33 L | NA | 114 ± 41 | 
            Table 2 Possible mechanisms associated with reduced exercise capacity in heart transplant recipients
        
    | Central factors | 
| Reduced cardiac output | 
| Chronotropic incompetence | 
| Reduced stroke volume | 
| Systolic dysfunction | 
| Diastolic dysfunction | 
| Pulmonary dysfunction | 
| Pulmonary hypertension | 
| Lung disease | 
| Pulmonary congestion | 
| Peripheral factors | 
| Decreased skeletal muscle function | 
| Reduced muscle mass | 
| Reduced muscle strength | 
| Reduced capillary density | 
| Reduced oxidative capacity | 
| Reduced mitochondrial function | 
| Corticosteroid induced myopathy | 
| Impaired vasodilatory capacity | 
| Endothelial dysfunction | 
| Deconditioning | 
| Potential factors contributing to reduced exercise capacity | 
| Increasing age | 
| Donor age | 
| Donor match | 
| Ischemic time | 
| Pre transplant de-conditioning | 
| Primary diagnosis | 
| Co-morbidities | 
| Smoking | 
| Cultural differences | 
| Gender differences | 
| Anxiety and depression | 
| Socio-economic status | 
| Reduced health-related quality of life | 
            Table 3 Summary of randomized controlled trials investigating the effect of exercise in heart transplant recipients
        
    | Study | n, mean age (yr) | Mean time after HTx | Intervention | Mean change in VO2peak (mL/kg per minute) within groups | Mean change in VO2peak (mL/kg per minute) between groups | 
| Kobashigawa et al[3] | 27, 52 | 1 mo | 6 mo partly supervised rehabilitation program vs controls CG | Ex: 9.2 → 13.6 | 2.5 | 
| Walking: cycling and upper and lower limb exercises for 30 min × 1-3/wk | Con: 10.4 → 12.3 | ||||
| Tegtbur et al[26] | 32, 55 | 5 yr | 1 yr home-based exercise program vs controls | Ex: 18.6 → 20.0 | 1.3 | 
| Cycling every other day for 1 yr at 80%-90% of maximum HR | Con: 18.9 → 19.0 | ||||
| Bernardi et al[6] | 24, 52 | 6 mo | 6 mo home training vs controls | Ex: 14.9 → 19.6 | 3.4 | 
| Cycling at 60%-70% of VO2peak 30 min × 5/wk × 6 mo | Con: 14.3 → 15.6 | ||||
| Karapolat et al[5] | 28, 42 | 1.5 yr | 8 wk supervised hospital training vs home-based training | ||
| 1.5 h of multiple exercises: including aerobic exercise for 30 min at 60%-70% of VO2peak× 3/wk | Ex: 16.7 → 19.5 | 3.4 | |||
| The controls received written guidelines on exercises and a walking program | Con: 20.1 → 19.5 | ||||
| Wu et al[27] | 37, 56 | 2 yr | 8 wk home training vs controls | ||
| Strength training and aerobic exercise at 60%-70% of VO2peak: 35-40 min × 3/wk | Ex: 12.1 → 13.2 | 1.6 | |||
| Con: 13.7 → 13.2 | |||||
| Haykowsky et al[25] | 43, 59 | 5 yr | 12 wk aerobic/strength training vs controls | ||
| First 8 wk: continuous aerobic exercise at 60%-80% of VO2peak: 30-45 min × 2/wk | |||||
| Continuous aerobic training at 80% of VO2peak, 45 min × 2/wk and bicycle interval training for 30 s at 90%-100% of VO2peak: followed by 60 s rest for 10-25 reps × 2/wk in the final 4 wk | Ex: 21.2 → 24.7 | 3.5 | |||
| Resistance training at 50% of 1RM: 10-15 reps × 1-2 sets × 4 exercises × 2/wk for 12 wk | Con: 18.2 → 18.2 | ||||
| Hermann et al[16] | 27, 50 | 7 yr | 8 wk high-intensity interval training vs controls | ||
| Interval blocks of 4 min/2 min/30 s: corresponding to 80%: 85% and 90% of VO2peak: respectively: and recovery periods of ½ min: and finally staircase running at 80% of VO2peak: followed by recovery walking 60 min × 3/wk | Ex: 23.9 → 28.3 | 5.6 | |||
| Con: 24.6 → 23.4 | |||||
| Nytrøen et al[18] | 48, 51 | 4 yr | 1 yr high-intensity interval training vs controls | ||
| 4 interval blocks of 4 min each performed at 91% of peak HR: with 3 min active recovery periods between each block | Ex: 27.7 → 30.9 | 3.6 | |||
| 3 periods of 8 wk distributed throughout 1 yr with exercise 3/wk for a total of 72 exercise sessions | Con: 28.5 → 28.0 | 
- Citation: Nytrøen K, Gullestad L. Exercise after heart transplantation: An overview. World J Transplant 2013; 3(4): 78-90
- URL: https://www.wjgnet.com/2220-3230/full/v3/i4/78.htm
- DOI: https://dx.doi.org/10.5500/wjt.v3.i4.78

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        